Synakis Announces Close of Oversubscribed Pre-Seed Round Co-Led by TIAP
Synakis Announces Close of Oversubscribed Pre-Seed Round TORONTO, May 21, 2026 /CNW/ - Synakis Corp., a Toronto-based biotechnology company developing ocular therapies for retinal disease and glaucoma, announced today the close of…
